Hipro Biotechnology Co.,Ltd
Hipro Biotechnology Co.,Ltd
Contact Us

Hipro Shines at 2025 ADLM: FDA-Approved A1 Instrument & Reagents Take Center Stage

Hipro, a leading player in the diagnostics and laboratory medicine field, achieved remarkable success at the 2025 Association for Diagnostics & Laboratory Medicine (ADLM) Annual Scientific Meeting, held from July 27 to 31 in Chicago, USA. Building on the momentum of its previous successful participations in international exhibitions, Hipro once again demonstrated its strength in innovative technologies and high-quality products, attracting extensive attention from new and old customers.


w700d1q75cms.jpg


The ADLM 2025 event, as a key gathering for professionals in the diagnostics and laboratory medicine sector, drew a large number of industry experts, practitioners, and decision-makers. Hipro, with its elegant and international exhibition style, set up an impressive booth that became a focal point throughout the meeting. The company's professional sales and service teams were on hand to engage with visitors, providing detailed introductions to products and solutions, and fostering in-depth exchanges with clients.


PHOTO_20250730_202033542(1).jpg


Among the standout products at Hipro's booth, the FDA-certified A1 instrument and HbA1c test kit took center stage. The A1 instrument, known for its stability, accuracy, and advanced performance, has long been recognized in global markets. With the FDA certification, it further solidifies its position as a reliable choice for clinical laboratories and medical institutions in the United States. The HbA1c test kit , perfectly matching the A1 instrument, ensure precise and efficient testing, meeting the stringent requirements of diabetes diagnosis and monitoring. Their exceptional quality and performance garnered significant interest from attendees, who showed strong enthusiasm for potential collaborations.


PHOTO_20250730_202033965(1).jpg


Equally attracting substantial attention were the ZOAN home self-test products and the PalmF. The ZOAN series, specifically designed for home use, empowers individuals to conveniently monitor their health status in the comfort of their own homes. These self-test products are user-friendly, with simple operation procedures that allow people to obtain accurate test results quickly, making them ideal for personal health management. The PalmF, continuing the legacy of portability and efficiency seen in previous iterations, offer flexibility and convenience for point-of-care testing. Their compact design and reliable performance make them suitable for various scenarios, including emergency situations and primary care settings, earning praise from many visitors.


PHOTO_20250730_202113927(1).jpg


During the exhibition, Hipro had fruitful interactions with numerous new and old customers. Existing clients expressed their satisfaction with Hipro's products and services, reaffirming their trust and willingness to continue cooperation. New customers were impressed by the innovation and quality of Hipro's offerings, initiating discussions on potential partnerships. Hipro also shared its concept of resource sharing, complementary advantages, and mutually beneficial cooperation with all attendees, laying a solid foundation for future collaborations.


PHOTO_20250730_202033758(1)(1).jpg


As the ADLM 2025 Annual Scientific Meeting came to a close, Hipro's successful participation not only enhanced its international reputation but also opened up new avenues for global cooperation. The company looks forward to continuing its journey of innovation and making greater contributions to the global healthcare industry.


Products